10118-90-8|2-Naphthacenecarboxamide,4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-,(4S,4aS,5aR,12aS)-Products Supply

2-Naphthacenecarboxamide,4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-,(4S,4aS,5aR,12aS)- cas no:10118-90-8

Synonyms: 2-Naphthacenecarboxamide,4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-(8CI);2-Naphthacenecarboxamide,4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-,[4S-(4a,4aa,5aa,12aa)]-;CL 59806;Dynacin;Minocyclin;Minocyn;Tri-minocycline;

Identification

Name2-Naphthacenecarboxamide,4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-,(4S,4aS,5aR,12aS)-
CAS10118-90-8
Synonyms2-Naphthacenecarboxamide,4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-(8CI);2-Naphthacenecarboxamide,4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-,[4S-(4a,4aa,5aa,12aa)]-;CL 59806;Dynacin;Minocyclin;Minocyn;Tri-minocycline;
EINECS(EC#)237-099-7
Molecular FormulaC₂₃H₂₇N₃O₇
Molecular Weight457.48

Chemical Properties

AppearanceBright yellow-orange amorphous solid.
refractive index1.717
storage tempKeep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.

Safety Data

Safety

Poison by intraperitoneal, intravenous, and intracerebral routes. Moderately toxic by ingestion. Human systemic effects by ingestion: interstitial nephritis, proteinuris and hematuris. Human mutation data reported. When heated to decomposition it emits toxic fumes of NO_x.

Toxicity

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
infant	TDLo	oral	12mg/kg/2D-I (12mg/kg)	BRAIN AND COVERINGS: INCREASED INTRACRANIAL PRESSURE GASTROINTESTINAL: NAUSEA OR VOMITING	Therapie. Vol. 38, Pg. 93, 1983.
man	TDLo	oral	343mg/kg/17W- (343mg/kg)	LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" LIVER: LIVER FUNCTION TESTS IMPAIRED BLOOD: EOSINOPHILIA	American Journal of Gastroenterology. Vol. 91, Pg. 1641, 1996.
mouse	LD50	intracrebral	38mg/kg (38mg/kg)	BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" BEHAVIORAL: EXCITEMENT MUSCULOSKELETAL: CHANGES IN TEETH AND SUPPORTING STRUCTURES	Chemotherapy Vol. 26, Pg. 196, 1980.
mouse	LD50	intraperitoneal	310mg/kg (310mg/kg)		"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 501, 1978.
mouse	LD50	intravenous	140mg/kg (140mg/kg)		"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 501, 1978.
mouse	LD50	oral	3100mg/kg (3100mg/kg)		"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 501, 1978.
women	TDLo	oral	8mg/kg (8mg/kg)	SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE"	American Journal of Medicine. Vol. 109, Pg. 340, 2000.
women	TDLo	oral	28mg/kg/2W-I (28mg/kg)	BRAIN AND COVERINGS: "CHANGES IN CIRCULATION (HEMORRHAGE, THROMBOSIS, ETC.)" BEHAVIORAL: HEADACHE SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE	Annals of Internal Medicine. Vol. 127, Pg. 168, 1997.
women	TDLo	oral	100mg/kg (100mg/kg)	KIDNEY, URETER, AND BLADDER: INTERSTITIAL NEPHRITIS KIDNEY, URETER, AND BLADDER: HEMATURIA KIDNEY, URETER, AND BLADDER: PROTEINURIS	British Medical Journal. Vol. 1, Pg. 524, 1979.
women	TDLo	oral	112mg/kg/4W-I (112mg/kg)	LIVER: LIVER FUNCTION TESTS IMPAIRED SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"	American Journal of Gastroenterology. Vol. 91, Pg. 1641, 1996.
women	TDLo	oral	730mg/kg/1Y-I (730mg/kg)	BEHAVIORAL: ANOREXIA (HUMAN GASTROINTESTINAL: NAUSEA OR VOMITING LIVER: LIVER FUNCTION TESTS IMPAIRED	American Journal of Gastroenterology. Vol. 91, Pg. 1641, 1996.
women	TDLo	oral	1204mg/kg/86W (1204mg/kg)	MUSCULOSKELETAL: JOINTS	British Journal of Rheumatology. Vol. 33, Pg. 674, 1994.
women	TDLo	oral	17520mg/kg/12 (17520mg/kg)	SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE MUSCULOSKELETAL: CHANGES IN TEETH AND SUPPORTING STRUCTURES SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"	American Journal of Ophthalmology. Vol. 125, Pg. 396, 1998.

supplier list

Nanjing Bangnuo Biotechnology Co., Ltd: Tel:86-1732-7098554; Address: shuanglong road,jiangning, nanjing,jiangsu

Hubei XinRunde Chemical Co., Ltd: Tel:86-27-83214668; Address: East and West Lake District, Wuhan, China

Hangzhou Dayangchem Co., Ltd.: Tel:86-571-88938639; Address: 9/F Unit 2 ChangdiTorch Building, 259 #WenSan Road

Hangzhou J&H Chemical Co., Ltd: Tel:86-571-87396430; Address: No.200 Zhenhua Rd.Xihu Industrial Park, Hangzhou 310030, China

Boc Sciences: Tel:1-631-5046093; Address: 45-16 Ramsey Road, Shirley, NY 11967, USA

Shanghai Forever Synthesis Co.,Ltd.: Tel:86-21-61124658; Address: Nianjiabang Rd, Pudong, Shanghai

Boc Sciences: Tel:1-631-5046093; Address: 45-16 Ramsey Road Shirley, NY 11967, USA

Andexin industrial Co.,Limited: Tel:86-411-39074598; Address: No.98,Shengli road,,Jinzhou district,

Shanghai FWD Chemicals ltd: Tel:86-21-34226250; Address: Room 802,Lotus Tower ,159 Tianzhou Road Xuhui Dist

Jinan Haohua Industry Co., Ltd.: Tel:0086-531-58773055; Address: No.59 Gongye South RD

AFINE CHEMICALS LIMITED: Tel:86-571-85232161; Address: 6th Floor, Block C, 7th Building, Xigang Xinjie, Xihu Industrial Park, Sandun Town, Hangzhou, China

Shanghai Hope Chem Co., Ltd.: Tel:86-21-61723543; Address: Room508, Building1, No.88 CaiLun Road Zhangjiang H

SPECS: Tel:+31 15 251 8111; Address: Kluyverweg 6

Beijing HuameiHuli Biochem Ltd: Tel:010-86181995; Address: Beijing TongZhou District

TaiZhou HiKong Chemical Co., Ltd.: Tel:+86-18967213045,13957694715; Address: Taizhou Economic Technical Development Zone, Taizhou, Zhejiang 318000,

2-Naphthacenecarboxamide,4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-,(4S,4aS,5aR,12aS)- cas no:10118-90-8

Directory

supplier list